Evidence map›Paper›PMID 31948734›Full record

ArticleNeuron2020

Endocannabinoid Signaling Collapse Mediates Stress-Induced Amygdalo-Cortical Strengthening.

David J Marcus, Gaurav Bedse, Andrew D Gaulden, James D Ryan, Veronika Kondev, Nathan D Winters, Luis E Rosas-Vidal, Megan Altemus, Ken Mackie, Francis S Lee and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Neuron, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 1 pooled it
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 1 synthesis or guideline pooled it, 106 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Serotonin-endocannabinoid crosstalk selectively regulates inhibitory GABAergic inputs in the medial prefrontal cortex.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Genetic Tools in Rodents to Study Cannabinoid Functions.Current topics in behavioral neurosciences · 2026
    Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Parvalbumin interneuron mGluNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

David J MarcusDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN 37232, USA; The Vanderbilt Brain Institute, Vanderbilt University, Nashville, TN 37232, USA.
Gaurav BedseDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Andrew D GauldenDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
James D RyanDepartment of Psychiatry, Weill Cornell Medicine, New York, NY 10065, USA; Sackler Institute for Developmental Psychobiology, Weill Cornell Medicine, New York, NY 10065, USA.
Veronika KondevDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN 37232, USA; The Vanderbilt Brain Institute, Vanderbilt University, Nashville, TN 37232, USA.
Nathan D WintersDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN 37232, USA; The Vanderbilt Brain Institute, Vanderbilt University, Nashville, TN 37232, USA.
Luis E Rosas-VidalDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Megan AltemusDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Ken MackieGill Center for Biomolecular Science, Indiana University, Bloomington, IN 47405, USA; Department of Psychological and Brain Sciences, Indiana University, Bloomington, IN 47405, USA.
Francis S LeeDepartment of Psychiatry, Weill Cornell Medicine, New York, NY 10065, USA; Sackler Institute for Developmental Psychobiology, Weill Cornell Medicine, New York, NY 10065, USA.
Eric DelpireDepartment of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Sachin PatelDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN 37232, USA; The Vanderbilt Brain Institute, Vanderbilt University, Nashville, TN 37232, USA; Departments of Pharmacology and Molecular Physiology & Biophysics, Vanderbilt University School of Medicine, Nashville, TN 37232, USA; Vanderbilt Center for Addiction Research, Nashville, TN 37232, USA. Electronic address: sachin.patel@vanderbilt.edu.
Vanderbilt University Medical Center · USCornell University · USIndiana University Bloomington · USVanderbilt University · USWeill Cornell Medicine · US

Funding

The Impact of the BDNF Val66Met Prodomain on Cognitive Function in a Mouse Model of Alzheimer's DiseaseR01NS052819 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI HEMPSTEAD, BARBARA L, LEE, FRANCIS SANG YONG · 2005 to 2019
$5.3M
2-Arachidonoylglycerol signaling in anxiety, depression, and stress adaptationR01MH107435 · NIMH · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PATEL, SACHIN · 2016 to 2025
$5.0M
Gene-Targeted Mouse CoreU01AA013514 · NIAAA · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DELPIRE, ERIC J · 2002 to 2016
$4.3M
Sex-specific critical periods determine the effects of cannabinoids on the mesocorticolimbic systemR01DA043982 · NIDA · TRUSTEES OF INDIANA UNIVERSITY · PI MACKIE, KENNETH, MANZONI, OLIVIER JJ · 2017 to 2021
$1.5M
Genetic and Environmental Influences on AddictionT32DA039080 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI Teresa A Milner · 2017 to 2026
$1.4M
Physiology and function of amygdalo-cortical endocannabinoid signalingF31MH114363 · NIMH · VANDERBILT UNIVERSITY · PI MARCUS, DAVID J. · 2017 to 2018
$58k
NIAAA NIH HHS U01 AA013514NIDA NIH HHS R01 DA043982NIDA NIH HHS T32 DA039080NIMH NIH HHS F31 MH114363NIMH NIH HHS R01 MH107435NINDS NIH HHS R01 NS052819
6 · The paper itself

Abstract

Functional coupling between the amygdala and the dorsomedial prefrontal cortex (dmPFC) has been implicated in the generation of negative affective states; however, the mechanisms by which stress increases amygdala-dmPFC synaptic strength and generates anxiety-like behaviors are not well understood. Here, we show that the mouse basolateral amygdala (BLA)-prelimbic prefrontal cortex (plPFC) circuit is engaged by stress and activation of this pathway in anxiogenic. Furthermore, we demonstrate that acute stress exposure leads to a lasting increase in synaptic strength within a reciprocal BLA-plPFC-BLA subcircuit. Importantly, we identify 2-arachidonoylglycerol (2-AG)-mediated endocannabinoid signaling as a key mechanism limiting glutamate release at BLA-plPFC synapses and the functional collapse of multimodal 2-AG signaling as a molecular mechanism leading to persistent circuit-specific synaptic strengthening and anxiety-like behaviors after stress exposure. These data suggest that circuit-specific impairment in 2-AG signaling could facilitate functional coupling between the BLA and plPFC and the translation of environmental stress to affective pathology.

Indexed as

AnimalsAnxietyArachidonic AcidsBasolateral Nuclear ComplexEndocannabinoidsGlutamic AcidGlyceridesMaleMiceNeural PathwaysPrefrontal CortexRestraint, PhysicalStress, PsychologicalSynaptic TransmissionArachidonic AcidsEndocannabinoidsGlutamic AcidGlyceridesglyceryl 2-arachidonate2-arachidonoylglycerolamygdalaanxietycannabinoidcannabisglutamateoptogeneticsposttraumatic stress disorderprefrontal cortexstress

Identifiers

PMID31948734
PMCPMC7992313
OpenAlexW2946990124

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.